FDA Inspection 1197605 — Qiagen GmbH
The FDA completed an inspection of Qiagen GmbH on November 4, 2022 in Hilden. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Devices.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- November 4, 2022
- Fiscal Year
- 2023
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- Hilden (Germany)
Additional Details
Postmarket Audit Inspections